Gene therapy, cell therapy and vaccine research have led to an increased need to perform cellular immunity testing in a regulated environment to ensure the safety and efficacy of these treatments. The most common method for the measurement of cellular immunity has been Enzyme-Linked Immunospot assays. However, there is a lack of regulatory guidance available …
Recommendations on ELISpot assay validation by the GCC Read More »
‘This is really about strengthening the local ecosystem’ Source: CBC News Federal Minister Navdeep Bains joined co-founder Mohammed Moin and Chris Palmer, provincial minister of economic development and tourism, to make the announcement. (Brittany Spencer/CBC) The Charlottetown-based bioscience company Somru BioScience will receive over $4 million in federal and provincial funding to support its latest research and development project. …
Somru BioScience gets $4M to research, develop affordable medicines Read More »
Challenges and Solutions Seminar Series Register now: http://www.somrubioscience.com/page/somru-seminar Ready to get started? Consult with a Scientist today! Let's Talk
News release Governments of Canada and Prince Edward Island contribute over $4 million to support latest Somru Bioscience research and development project July 11, 2018 – Charlottetown, PE – Atlantic Canada Opportunities Agency Innovation is not a buzzword. It is a way of life and a driving force in today’s economy. It is about making …
Somru developed the following comprehensive list of bioanalytical assays to support Denosumab biosimilar development Pharmacokinetic Assay (PK) assay ADA assay Binding ADA assay Cell-based NAb assay(s) Ligand Binding NAb Assay Pharmacodynamic Assays sCTX TRAP-5b P1NP PK Assays to support Denosumab Somru has developed an assay to support the pharmacokinetic measurement of Denosumab This assay utilizes the …
A comprehensive bioanalytical solution for Denosumab(Prolia®, Xgeva®) Read More »